Brandes Investment Partners’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-4,723,376
| Closed | -$14.9M | – | 161 |
|
|
2020
Q3 | $14.9M | Sell |
4,723,376
-627,756
| -12% | -$1.98M | 0.51% | 56 |
|
|
2020
Q2 | $15.6M | Sell |
5,351,132
-382,440
| -7% | -$1.11M | 0.47% | 59 |
|
|
2020
Q1 | $16.2M | Sell |
5,733,572
-77,508
| -1% | -$219K | 0.57% | 56 |
|
|
2019
Q4 | $18.9M | Buy |
5,811,080
+345,924
| +6% | +$1.12M | 0.45% | 60 |
|
|
2019
Q3 | $11.8M | Buy |
5,465,156
+1,293,185
| +31% | +$2.79M | 0.31% | 69 |
|
|
2019
Q2 | $13.1M | Sell |
4,171,971
-173,112
| -4% | -$544K | 0.29% | 70 |
|
|
2019
Q1 | $16.2M | Sell |
4,345,083
-118,020
| -3% | -$439K | 0.38% | 63 |
|
|
2018
Q4 | $12.9M | Buy |
4,463,103
+526,384
| +13% | +$1.53M | 0.33% | 66 |
|
|
2018
Q3 | $10.4M | Buy |
3,936,719
+3,663,908
| +1,343% | +$9.64M | 0.23% | 65 |
|
|
2018
Q2 | $638K | Sell |
272,811
-547,930
| -67% | -$1.28M | 0.01% | 117 |
|
|
2018
Q1 | $2.41M | Sell |
820,741
-279,777
| -25% | -$822K | 0.05% | 104 |
|
|
2017
Q4 | $3.02M | Sell |
1,100,518
-12,161
| -1% | -$33.3K | 0.06% | 113 |
|
|
2017
Q3 | $3.77M | Buy |
1,112,679
+5,369
| +0.5% | +$18.2K | 0.08% | 104 |
|
|
2017
Q2 | $2.88M | Buy |
1,107,310
+1,048,732
| +1,790% | +$2.73M | 0.05% | 104 |
|
|
2017
Q1 | $133K | Buy |
+58,578
| New | +$133K | ﹤0.01% | 160 |
|